Home
Mail
News
Sports
Finance
Celebrity
Style
Movies
Weather
Mobile
Yahoo
Mail
Finance Home
News
Video
Watchlists
My Portfolio
Real Estate
My Screeners
Tech
Market Data
Industry News
Currency Converter
Canada markets closed
S&P/TSX
20,714.48
+13.98
(+0.07%)
S&P 500
4,070.56
+10.13
(+0.25%)
DOW
33,978.08
+28.68
(+0.08%)
CAD/USD
0.7504
-0.0002
(-0.03%)
CRUDE OIL
79.38
-1.63
(-2.01%)
BTC-CAD
31,835.56
+952.96
(+3.09%)
Canntab Therapeutics Limited (TBF1.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0005
0.0000
(0.00%)
At close: 08:00AM CET
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
All numbers in thousands
Breakdown
ttm
2022-05-31
2021-05-31
2020-05-31
2019-05-31
Total Revenue
297.356
293.362
0
133.334
239.999
Cost of Revenue
212.873
223.894
-
-
-
Gross Profit
84.483
69.468
-
-
-
Operating Expenses
Research Development
188.512
205.031
80.357
105.746
128.144
Selling General and Administrative
2,481
2,827
2,704
2,339
2,437
Total Operating Expenses
3,226
3,667
3,331
2,749
2,742
Operating Income or Loss
-3,141
-3,597
-3,331
-2,616
-2,502
Interest Expense
659.169
566.672
188.722
-
-
Total Other Income/Expenses Net
247.254
474.834
-900.3
-
-
Income Before Tax
-3,553
-3,689
-4,420
-2,607
-2,459
Income from Continuing Operations
-3,553
-3,689
-4,420
-2,607
-2,459
Net Income
-3,553
-3,689
-4,420
-2,607
-2,459
Net Income available to common shareholders
-3,553
-3,689
-4,420
-2,607
-2,459
Basic EPS
-
-0.10
-0.13
-0.10
-0.10
Diluted EPS
-
-0.10
-0.13
-0.10
-0.10
Basic Average Shares
-
37,724
34,553
27,169
25,299
Diluted Average Shares
-
37,724
34,553
27,169
25,299
EBITDA
-
-2,488
-3,685
-2,320
-2,421
© 2023 Yahoo. All rights reserved.
Data Disclaimer
Help
Suggestions
Terms (Updated)
Privacy
Privacy Dashboard
About Our Ads